Taylor Wessing advises Xention Discovery Ltd on its £11m venture capital funding
Venture Capital funding
Taylor Wessing's Cambridge office has advised Xention Discovery Ltd, an emerging pharmaceutical company specialising in ion channel drug discovery, on its £11m Series B financing.